C9507 HCPCS Level II code: Plasma, high titer covid-19 convalescent, each unit
C9507 is the HCPCS code for “Plasma, high titer covid-19 convalescent, each unit” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9507Plasma, high titer covid-19 convalescent, each unit
Short description: Covid-19 convalescent plasma
HCPCS · United States
Medicare details
The indicators CMS publishes with C9507 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services
- BETOS category
- Lab tests - other (Non-Medicare fee schedule)
- Coverage statute
- 1833(t)
- Added
- Dec 28, 2021
Where C9507 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9507Plasma, high titer covid-19 convalescent, each unit
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9507 mean?
C9507 is the HCPCS code for “Plasma, high titer covid-19 convalescent, each unit” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9507?
CMS lists C9507’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9507
All C codesC9490Injection, bezlotoxumab, 10 mgC9491Injection, avelumab, 10 mgC9492Injection, durvalumab, 10 mgC9493Injection, edaravone, 1 mgC9494Injection, ocrelizumab, 1 mgC9497Loxapine, inhalation powder, 10 mgC9600Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branchC9601Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list…C9602Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branchC9603Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery…C9604Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary…C9605Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary…